Literature DB >> 24317162

Sewage epidemiology and illicit drug research: the development of ethical research guidelines.

Jeremy Prichard1, Wayne Hall2, Pim de Voogt3, Ettore Zuccato4.   

Abstract

AIMS: To discuss the need to develop ethical guidelines for researchers using sewage epidemiology to monitor drug use in the general population and specific precincts, including prisons, schools and workplaces.
METHOD: Describe current applications of sewage epidemiology, identify potential ethical risks associated with this science, and identify key means by which these risks may be mitigated through proportionate ethical guidance that allows this science to be fully developed.
RESULTS: A rapidly advancing field of research is sewage epidemiology (SE) - the analysis of wastewater samples to monitor illicit drug use and other substances. Typically this research involves low ethical risks because individual participants cannot be identified and, consequently, review has been waived by human research ethics committees. In the absence of such oversight, ethical research guidelines are recommended for SE teams, peer reviewers and journal editors; guidelines will assist them to mitigate any risks in general population studies and studies of prisons, schools and workplaces. Potential harms include the stigmatisation of participants and, in the prison setting, austere policy responses to SE data that impact negatively upon inmate-participants. The risk of harm can be managed through research planning, awareness of the socio-political context in which results will be interpreted (or, in the case of media, sensationalised) and careful relations with industry partners. Ethical guidelines should be developed in consultation with SE scholars and be periodically amended. They should include publication processes that safeguard scientific rigour and be promulgated through existing research governance structures.
CONCLUSIONS: Guidelines will assist to promote an ethical research culture among SE teams and scholars involved in the publication process and this will work to protect the reputation of the field.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Ethical; Ethics; Sewage epidemiology; Wastewater analysis

Mesh:

Substances:

Year:  2013        PMID: 24317162     DOI: 10.1016/j.scitotenv.2013.11.039

Source DB:  PubMed          Journal:  Sci Total Environ        ISSN: 0048-9697            Impact factor:   7.963


  6 in total

1.  Wastewater-Based Epidemiology of Stimulant Drugs: Functional Data Analysis Compared to Traditional Statistical Methods.

Authors:  Stefania Salvatore; Jørgen Gustav Bramness; Malcolm J Reid; Kevin Victor Thomas; Christopher Harman; Jo Røislien
Journal:  PLoS One       Date:  2015-09-22       Impact factor: 3.240

2.  Monitoring wastewater for assessing community health: Sewage Chemical-Information Mining (SCIM).

Authors:  Christian G Daughton
Journal:  Sci Total Environ       Date:  2017-11-29       Impact factor: 7.963

3.  Wastewater-based epidemiology pilot study to examine drug use in the Western United States.

Authors:  Nicholas Bishop; Tammy Jones-Lepp; Miranda Margetts; Jordan Sykes; David Alvarez; Deborah E Keil
Journal:  Sci Total Environ       Date:  2020-07-15       Impact factor: 7.963

4.  Detecting SARS-CoV-2 RNA prone clusters in a municipal wastewater network using fuzzy-Bayesian optimization model to facilitate wastewater-based epidemiology.

Authors:  Srinivas Rallapalli; Shubham Aggarwal; Ajit Pratap Singh
Journal:  Sci Total Environ       Date:  2021-03-08       Impact factor: 7.963

5.  Population Health Metrics During the Early Stages of the COVID-19 Pandemic: Correlative Pilot Study.

Authors:  Marie A Severson; David A Cassada; Victor C Huber; Daniel D Snow; Lisa M McFadden
Journal:  JMIR Form Res       Date:  2022-10-17

6.  Presence of Illicit Drugs and Pharmaceutical Residues in the Wastewaters of an Eastern Canadian City.

Authors:  A Palardy; J-P Gagné; L Tremblay
Journal:  J Xenobiot       Date:  2016-02-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.